ENCare AB

Based in Sweden, ENCare AB operates as a healthcare technology company focused on enhancing patient recovery through tailored surgical care solutions. Founded in 2009, ENCare AB specializes in healthcare technology, particularly in implementing Enhanced Recovery After Surgery (ERAS) protocols. The company is headquartered in Stockholm, Sweden, and has completed three deals, with the most recent funding round on May 25, 2023, securing EUR 1. 5 mn from investor Sciety.

The company has raised a total of EUR 1. 5 mn. Per Sunnemark is the current CEO. ENCare provides a comprehensive suite of products and services centered around Enhanced Recovery After Surgery (ERAS) protocols, enhancing patient outcomes across various surgical settings.

Their primary offering, the ERAS® Interactive Audit System (EIAS), enables healthcare facilities to track compliance with ERAS guidelines and improve care processes. This system is employed by multidisciplinary clinical teams in hospitals, with a focus on surgical disciplines including Bariatric, Breast Reconstruction, Cardiac, Colorectal, Gynecology, and Urology. Their clientele mainly comprises hospitals and surgical centers across Europe, particularly in Sweden, Italy, and Ukraine. In 2022, ENCare generated revenue of EUR 1,901,186.

20 with an EBITDA of EUR -598,262. 30. Their revenue model involves annual subscriptions for the ERAS® Interactive Audit System (EIAS), granting healthcare providers access to critical insights and compliance tracking, further strengthened by partnerships with the ERAS® Society and institutions like the National Cancer Institute of Ukraine. In May 2023, ENCare AB raised EUR 1.

5 mn in venture funding to accelerate growth, enhance product development, and expand into global markets. The company plans to leverage this funding to introduce new products that align with their ERAS protocols, targeting further penetration into European markets and exploring opportunities in other regions by specific timelines as their strategy unfolds.